Atlas Trials

A Novel Formulation of Bifidobacterium Longum BB536 and Lactobacillus Rhamnosus HN001 With Vitamin B6 on IBS Patients

Clinical trial NCT03815617 · COMPLETED

Trial details

NCT number
NCT03815617
Sponsor
University of Bari
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Irritable Bowel Syndrome
Start date
2017-02-01
Primary completion
2018-05-31
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.